Fibroblast growth factor receptor (FGFR) inhibitors as anticancer agents: 3D-QSAR, molecular docking and dynamics simulation studies of 1, 6-naphthyridines and pyridopyrimidines-Reference-Cited by-同舟云学术

Fibroblast growth factor receptor (FGFR) inhibitors as anticancer agents: 3D-QSAR, molecular docking and dynamics simulation studies of 1, 6-naphthyridines and pyridopyrimidines

Published:2022-03-23 Issue:8 Volume:41 Page:3591-3606
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Modh Dharti H.¹,Modi Siddharth J.¹^ORCID,Deokar Hemant²,Yadav Savita¹,Kulkarni Vithal M.¹^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Pune, Maharashtra, India

2. Department of Pharmaceutical Sciences, College of Pharmacy, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2022.2053206

Reference26 articles.

1. Combined 2D and 3D-QSAR, molecular modelling and docking studies of pyrazolodiazepinones as novel phosphodiesterase 2 inhibitors

2. Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters

3. Quantitative Structure-Activity Relationship of Organosulphur Compounds as Soybean 15-Lipoxygenase Inhibitors Using CoMFA and CoMSIA

4. Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application

5. Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer Drug Discovery By Structure-Based Repositioning Approach;Mini-Reviews in Medicinal Chemistry;2024-01

2. From nature to cancer therapy: Evaluating the Streptomyces clavuligerus secondary metabolites for potential protein kinase inhibitors;Journal of Cellular Biochemistry;2023-12-04

3. Molecular simulations required to target novel and potent inhibitors of cancer invasion;Expert Opinion on Drug Discovery;2023-09-07

4. Sanggenol B, a plant bioactive, as a safer alternative to tackle cancer by antagonising human FGFR;Journal of Biomolecular Structure and Dynamics;2023-08-08

5. Synthesis, anti-angiogenic activity and prediction toxicity of (E)-3-(3-methoxyphenyl) propenoic acid;Journal of Public Health in Africa;2023-03-16